Can first trimester maternal serum follistatin like 3 levels predict developing gestational diabetes mellitus? 2017

Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
a Kirklareli University, Medical Science High School , Kirklareli , Turkey.

OBJECTIVE The purpose of this study is to determine whether the first trimester maternal serum levels of follistatin like 3 (FSTL3) are altered in patients who develop gestational diabetes mellitus (GDM). METHODS This is a prospective nested case-control study that included 170 singleton pregnant women recruited in their first trimester. All women were followed up until the delivery and 144 of them completed the study. The maternal serum levels of FSTL3 were measured at 11-14 weeks of gestation. The GDM-affected women (n = 19) were compared with the GDM-free control women (n = 125) for potential serum biomarkers including the FSTL3 levels. RESULTS There were no significant differences in maternal age, maternal pre-pregnancy body mass index, and neonatal birth weight between the GDM group and the GDM-free control group. Women with GDM had significantly greater weight gain during pregnancy than the women without GDM. Serum concentration of glycosylated hemoglobin was significantly higher in women with GDM. There were no significant differences in serum FSTL3 levels (p = 0.578) between the GDM group and the GDM-free control group. CONCLUSIONS Our results suggest that the first trimester maternal serum FSTL3 levels are not altered in women who develop GDM and thus do not support the use of serum FSTL3 levels for early prediction of GDM.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016640 Diabetes, Gestational Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA. Diabetes Mellitus, Gestational,Diabetes, Pregnancy-Induced,Gestational Diabetes,Diabetes, Pregnancy Induced,Gestational Diabetes Mellitus,Pregnancy-Induced Diabetes
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D038702 Follistatin-Related Proteins Broadly distributed glycoproteins that are homologous to the activin-binding protein, FOLLISTATIN. These follistatin-related proteins are encoded by a number of genes. FLRG Protein,FSTL1 Gene Product,FSTL3 Gene Product,Follistatin Secreted Related Protein,Follistatin-Like Protein 1,Follistatin-Like Protein 3,Follistatin-Like Secreted Glycoprotein,Follistatin-Related Protein 1,Follistatin Like Protein 1,Follistatin Like Protein 3,Follistatin Like Secreted Glycoprotein,Follistatin Related Protein 1,Follistatin Related Proteins

Related Publications

Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
March 2010, Diabetes care,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
January 2022, Frontiers in endocrinology,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
January 2024, Journal of clinical medicine,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
June 2022, Placenta,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
June 2016, Turkish journal of obstetrics and gynecology,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
August 2005, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
October 2021, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
January 2022, International journal of endocrinology,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
March 2018, Biomarkers in medicine,
Ayse Yasemin Karageyim Karsidag, and Yunus Emre Purut, and Esra Esim Buyukbayrak, and Asuman Orcun, and Mehmet Menke
March 2012, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!